New insights expand available psoriasis treatments
New psoriasis treatments are making their way to market. This supplement and the corresponding August issue take a broad look at the evolving understanding of the pathogenesis of psoriasis, the expanding treatment armamentarium, co-morbidity considerations, and financial considerations of new technologies.
(Nikkikii - stock.adobe.com)
Psoriasis affects about 125 million individuals worldwide and is associated with significant comorbidities. With new treatments making their way to market, this supplement and the corresponding main issue take a broad look at the evolving understanding of the pathogenesis of psoriasis, the expanding treatment armamentarium, co-morbidity considerations, and financial considerations of new technologies. Together, the articles offer insight into how to formulate a treatment plan specific to your patient.
View the supplement here.
